Srinivas Vinod Saladi

Srinivas Vinod Saladi

Company: Harvard Medical School  

Job title: Assistant Professor


Panel Discussion: An Overview of the Hippo Pathway Drug Development Landscape 9:00 am

What indications are showing most promise for therapeutic intervention on the Hippo pathway? Will targeted approaches on TEAD isoforms be the key to navigating risk of toxicity from pan-TEADs? How do we convince investors Hippo pathway treatments are worth their time when some consider the pathway ‘unvalidated’? What are the advantages/risks in targeting YAP/TAZ and…Read more

day: Conference Day One

Workshop C – A Deep-Dive into Identification of Inhibitors of TEAD to Bolster your Drug Development Pipeline 3:00 pm

TEAD Inhibition remains the key method of targeting the Hippo pathway for targeted drug development in YAP dependent cancers. Here we will provide pharmacological insight into potential future drug development candidate inhibitors for TEAD. Attend this Workshop to: Visualize crystal structures of TEAD binding residues with potential candidate compounds Review the therapeutic opportunities and limitations…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.